The DNA-activated serine/threonine protein kinase (DNA-PK) is composed of a large catalytic polypeptide (DNA-PK,,) and Ku, a heterodimeric DNA-binding component (p7O/p8O) that targets DNA-PKc, to DNA. A 41-kbp segment of the DNA-PK¢, gene was isolated, and a 7902-bp segment was sequenced. The sequence contains a polymorphic Pvu II restriction enzyme site, and comparing the sequence with that of the cDNA revealed the positions of nine exons. The DNA-PK& gene was mapped to band qll of chromosome 8 by in situ hybridization. This location is coincident with that of XRCC7, the gene that complements the DNA double-strand break repair and V(D)J recombination defects (where V is variable, D is diversity, and J is joining) of hamster V3 and murine severe combined immunodeficient (scid) cells.
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DNA-activated serine/threonine protein kinase (DNA-PK) is a nuclear protein kinase that is activated in vitro by doublestranded DNA structures (for review, see refs. [1] [2] [3] [4] . Human DNA-PK activity copurifies with a large (>300 kDa) moderately abundant catalytic polypeptide [DNA-PK,,s (5, 6) ] but a second component, Ku, that targets DNA-PKcs to DNA is required for the phosphorylation of most substrates (7, 8) . Ku is a heterodimeric DNA-binding protein composed of two polypeptides, one of "70 kDa and the other of "80 kDa (p70/p80); it was originally identified as a human autoantigen associated with lupus and scleroderma overlap syndromes (9) . Although some sequence selectivity has been reported, most evidence indicates that Ku binds to duplex DNA ends and to DNAs with single-to double-strand transitions (10) (11) (12) . DNA-PK is activated by the DNA structures that bind Ku (13) and in vitro phosphorylates a variety of nuclear DNA-binding regulatory proteins, including the tumor suppressor protein p53 and replication factor A (for review, see refs. 1 and 2).
These findings suggest roles for DNA-PK in regulating nuclear processes and cell cycle progression in response to DNA damage or changes in DNA structure (2) (3) (4) . Nevertheless, the consequences of DNA-PK-mediated phosphorylations are largely unknown.
We have undertaken cloning of the DNA-PK catalytic subunit cDNA, and these efforts revealed an "13. (Fig. 1) . The sequences at the ends of a 7.4-kbp EcoRI fragment (in plasmid p274) from phage AgA3 correspond to sequences at the ends of a 1030-bp EcoRI fragment from the DNA-PKc, cDNA. The EcoRI site end of the corresponding 7-kbp EcoRINot I fragment in plasmid p282 (from AgA15) has the same end sequence as the end of the 1030-bp cDNA fragment closest to the 5' end of the mRNA. The sequence at the EcoRI site end of the 2.8-kbp EcoRI-Not I fragment in plasmid p276 is identical to sequence immediately after the distal EcoRI site creating the 1030-bp cDNA fragment. One end of the 6.6-kbp EcoRI fragment from each A phage is identical to the cDNA sequence immediately before the proximal EcoRI site of the 1030-bp cDNA fragment. This information revealed the relative positions and orientations of the restriction fragments in the subclones of AgA3 and AgA15 (Fig. 1) .
Next, both strands of the 7.4-kbp EcoRI fragment in plasmid p274 and the corresponding 7-kbp EcoRI-Not I fragment in plasmid p282 were sequenced. Over corresponding segments, both sequences are identical except for 1 nt (nt 6721 in the sequence L27425) that creates a Pvu II site in the AgAlS DNA that is not present in AgA3. The insert in the AgA15 DNA extends 1.6 kbp further toward the 5' end of the DNA-PK,, gene than the insert in AgA3, while the insert in this phage extends 2.8 kb further into the distal part of the gene (Fig. 1) .
A search of the GenBank database (release 79) revealed identity with two expressed sequence tags from clone HF-BCG90, a putative cDNA clone containing a 2.6-kb insert (18) . The two expressed sequence tags matched sequences 2.6 kb apart on opposite strands in our genomic sequence. That the HFBCG90 insert represents a genomic rather than a cDNA fragment was confirmed by DNA sequencing. Fig. 2 . The first four digits of the code are the CEPH family number; 01 as the last two digits indicates the father, and 02 is the mother. B). This position was confirmed using as probes plasmids p281 and p282, spanning --14 kb of the DNA-PK, gene. Chromosome length measurements (23) (Fig. 3C) . DNA-PK,, and D8S41, an anonymous marker mapped to 8p12-qll.23, are essentially coincident (Fig. 4) .
DISCUSSION
Five overlapping A genomic clones that span a 41-kbp segment of the DNA-PK,, gene were isolated, and an 8-kbp portion of this segment was sequenced and found to contain nine exons and eight introns. The exon sequences match exactly the corresponding cDNA sequence, validating the accuracy of this 1248-bp cDNA segment (the 1030-bp fragment plus the ends of the first and ninth exons). The predicted intron-exon boundaries fit well with the GT-AG rule for splice site selection (25) except for the last exon-intron border, which has CA instead ofAG at the exon donor site ( Table 1 ). The average length of the nine exons is 139 bp while that of the eight introns is 795 bp; these values are close to averages for exons and introns from vertebrates, 137 bp and 1127 bp, respectively (25) . An exon also was identified at a Sal I site near the 3' end of the 41-kb genomic segment (Fig. 1) ; by using this exon as the 3' reference point, the intron/exon length ratio is 12.4. The DNA-PKc, mRNA is 13.4 kb (K.O.H. et al., unpublished data); thus, extrapolation suggests a gene size of 110-180 kbp and an exon content approaching 100. DNA-PKYc is one of the largest protein kinase catalytic polypeptides yet identified; to our knowledge, twitchin and titin, two muscle-specific polypeptides with kinase catalytic domains, are larger (27) .
The DNA-PK& gene was mapped to chromosome 8 band qil by using probes derived from both a 3.2-kbp cDNA segment and genomic probes spanning a 14-kbp portion of the corresponding gene segment. The fact that hybridization was observed only with the pericentric region of chromosome 8 suggests that closely related sequences are not present elsewhere in the genome. Genes previously mapped to this region include MOS, the gene for a serine/threonine kinase related to the Moloney murine sarcoma viral oncogene product (28) ; CEBPD, the gene for the CCAAT/enhancer-binding transcription factor C/EBP-8 (29); andXRCC7 (HYRCI), a human gene that partially complements the deficiencies of rodent cells from ionizing radiation group 7 (14) .
Four of nine ionizing radiation sensitivity complementation groups of rodent cells are defective or deficient in DNA double-strand break repair (30) . Three of these four-XRCC4 (x-ray cross-complementing group 4), XRCC5, and XRCC7 (scid)-also are defective in V(D)J recombination, thus linking recombination and DNA double-strand break repair in mammalian cells. The genes for the two subunits of Ku were mapped to chromosome 2 (p80) and chromosome 22 (p70) (31) , and the Ku p80 polypeptide was shown to be encoded by XRCC5, one of the genes required for DNA double-strand break repair and V(D)J recombination (32, 33 The qil region of human chromosome 8 has not been associated with a human disease, nor does the region contain a known locus for radiation sensitivity; however, chromosome 8 partially corrects the ionizing radiation sensitivity and V(D)J recombination deficiency of cells from the scid mouse (15, 16) , and the responsible human gene was localized to band qll (14) . The scid mutation prevents normal B-and T-cell development, presumably by inactivating or preventing expression of a component(s) required to resolve DNA structures produced during V(D)J recombination (34, 35) , and this component also is required for repairing DNA double-strand breaks (36) (37) (38) (39) . DNA-PK is activated by DNA ends and structures with single-to double-strand transitions (13) , precisely the structures generated during recombination and by ionizing radiation. Although DNA-PK is 50-100 times less abundant in rodent cells than in human cells (1), a peptide-based "pulldown" assay was used to show that DNA-PK activity is deficient in extracts of hamster xrs-6 (XRCC5 defective) and V3 cells, and in murine scid cells (17, 40) . In the latter two cases, the absence of activity is due to a specific deficiency in DNA-PKcs (17) . Furthermore, activity was restored by yeast artificial chromosomes containing the entire human DNAPKc, gene. Although the scid mutation has not been identified, our estimate for the size of the DNA-PKcs gene suggests that not many other genes can be present on the complementing yeast artificial chromosomes. Thus, these findings imply that DNA-PKcs is the product of XRCC7 and suggest that the murine scid and hamster V3 mutations lie within the DNA-PK,, gene. Genetics: Sipley et aL may inhibit nuclear activities that might interfere with DNA double-strand break repair or the resolution of recombination structures. Consistent with the latter idea, DNA-PK recently was found to inhibit RNA polymerase I transcription from linear templates (41) . DNA-PK also is capable of phosphorylating the C-terminal domain of the large subunit of RNA polymerase II in vitro (42) and might similarly act to block RNA polymerase II-mediated transcription. Furthermore, DNA-PK hyperphosphorylates replication protein A (43) , and a similar hyperphosphorylation is observed after treating cells with DNA damage-inducing agents (44, 45) . (iii) DNA doublestrand breaks induce the accumulation of p53, which leads to an arrest of cell cycle progression in late G1 phase (46) . The upstream factors that detect DNA breaks and signal the accumulation of p53 have not been identified, but DNA-PK could be involved. Consistent with this possibility, DNA-PK phosphorylates Ser-15, a site conserved among mammalian p53 proteins (47) , and changing this site to alanine increases the half-life of the mutant p53 (48). It is not known, however, whether phosphorylation at this site contributes to the transient stabilization of p53 that occurs after DNA damage. Furthermore, there may be insufficient DNA-PK in rodent cells to rapidly produce a checkpoint signal in response to DNA strand breaks. A need to detect DNA breaks rapidly may have provided the selective force that led to the significantly higher levels of DNA-PK expression seen in somatic cells of longer lived primates. 
